THE NUCLEAR RECEPTOR LRH-1 IS A THERAPEUTIC TARGET FOR INFLAMMATORY BOWEL DISEASE (IBD)

被引：0
|
作者：
Wang, Hongtao
Wang, Guohui
Moore, David D.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1881
引用
收藏
页码：S647 / S648
页数：2
相关论文
共 50 条
  • [41] The sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis: a unique therapeutic target in inflammatory bowel disease
    Wang, Jie
    Goren, Idan
    Yang, Bo
    Lin, Sinan
    Li, Jiannan
    Elias, Michael
    Fiocchi, Claudio
    Rieder, Florian
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (03) : 277 - 291
  • [42] Formylated Peptide Receptor-1-Mediated Gut Inflammation as a Therapeutic Target in Inflammatory Bowel Disease
    McAllister, Milly J.
    Hall, Rebecca
    Whelan, Robert J.
    Fischer, Lena J.
    Chuah, Cher S.
    Cartlidge, Peter D.
    Drury, Broc
    Rutherford, Duncan G.
    Duffin, Rodger M.
    Cartwright, Jennifer A.
    Dorward, David A.
    Rossi, Adriano G.
    Ho, Gwo-tzer
    CROHNS & COLITIS 360, 2024, 6 (01)
  • [43] Functional cross-talk between nuclear receptor LRH-1 and androgen receptor signalling in prostate cancer
    You, Wenxing
    Wang, Yuliang
    Chan, Leung
    CANCER RESEARCH, 2018, 78 (13)
  • [44] Regulation of anti-atherogenic apolipoprotein m gene expression by the orphan nuclear receptor LRH-1
    Venteclef, Nicolas
    Haroniti, Anna
    Tousaint, Jean-Jacques
    Talianidis, Iannis
    Delerive, Philippe
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (07) : 3694 - 3701
  • [45] Molecular dynamics simulations of human LRH-1: The impact of ligand binding in a constitutively active nuclear receptor
    Burendahl, Sofia
    Treuter, Eckardt
    Nilsson, Lennart
    BIOCHEMISTRY, 2008, 47 (18) : 5205 - 5215
  • [46] ROLE OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN INFLAMMATORY BOWEL-DISEASE (IBD)
    MITSUYAMA, K
    TOYONAGA, A
    SASAKI, E
    NISHIYAMA, T
    TSURUTA, O
    HARADA, K
    TORIMURA, T
    TANIKAWA, K
    GASTROENTEROLOGY, 1993, 104 (04) : A747 - A747
  • [47] Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
    Zhou, Mengjiao
    Wang, Danfeng
    Li, Xiang
    Cao, Ying
    Yi, Chengxue
    Wiredu Ocansey, Dickson Kofi
    Zhou, Yuling
    Mao, Fei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [48] Intestinal microflora as a therapeutic target in inflammatory bowel disease
    Keiichi Mitsuyama
    Atsushi Toyonaga
    Michio Sata
    Journal of Gastroenterology, 2002, 37 : 73 - 77
  • [49] Intestinal microflora as a therapeutic target in inflammatory bowel disease
    Mitsuyama, K
    Toyonaga, A
    Sata, M
    JOURNAL OF GASTROENTEROLOGY, 2002, 37 (Suppl 14) : 73 - 77
  • [50] Microecology as a target for therapeutic intervention in inflammatory bowel disease
    Guarner, F
    IDRUGS, 2003, 6 (09) : 868 - 873
12345